Advertisement

Acta Neuropathologica

, Volume 137, Issue 1, pp 179–181 | Cite as

Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion

  • Jason ChiangEmail author
  • James Dalton
  • Santhosh A. Upadhyaya
  • Zoltán Patay
  • Ibrahim Qaddoumi
  • Xiaoyu Li
  • Annette D. Segura
  • Suash Sharma
  • Azzam Ismail
  • Sheila A. Shurtleff
  • Susana C. Raimondi
Correspondence

We previously described a series of localized intramedullary glioneuronal tumors limited to the spinal cord with histomorphologic, immunophenotypic, and molecular characteristics of diffuse leptomeningeal glioneuronal tumor (DLGNT), a newly added provisional entry in the current World Health Organization classification of central nervous system tumors [1, 3]. These localized spinal tumors and DLGNTs are characterized by the concomitant presence of KIAA1549BRAF fusion and chromosome arm 1p deletion [6]. Both have OLIG2-expressing oligodendrocyte-like tumor cells that are positive for synaptophysin and negative for GFAP [5]. Neuropil-like islands surrounded by neurocytic cells and variable amounts of ganglion cell differentiation are additional distinct features of both diseases [1]. However, despite this histomorphologic, immunophenotypic, and molecular resemblance, it remains uncertain whether the localized spinal BRAF-fused and 1p-deleted glioneuronal tumors are nosologically...

Notes

Acknowledgements

We thank Emily Walker in the Hartwell Center at St. Jude for technical assistance in genome-wide DNA methylation profiling and Vani Shanker in the Department of Scientific Editing at St. Jude for editing this manuscript.

Funding

JC receives funding from the American Lebanese Syrian Associated Charities (ALSAC) through St. Jude Children’s Research Hospital Department of Pathology.

Supplementary material

401_2018_1940_MOESM1_ESM.docx (46 kb)
Supplementary material 1 (DOCX 46 kb)

References

  1. 1.
    Chiang JCH, Harreld JH, Orr BA, Sharma S, Ismail A, Segura AD et al (2017) Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination. Acta Neuropathol 134:159–162.  https://doi.org/10.1007/s00401-017-1728-4 CrossRefGoogle Scholar
  2. 2.
    Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU et al (2018) Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathol 136:239–253.  https://doi.org/10.1007/s00401-018-1865-4 CrossRefGoogle Scholar
  3. 3.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820.  https://doi.org/10.1007/s00401-016-1545-1 CrossRefGoogle Scholar
  4. 4.
    Lyle MR, Dolia JN, Fratkin J, Nichols TA, Herrington BL (2015) Newly identified characteristics and suggestions for diagnosis and treatment of diffuse leptomeningeal glioneuronal/neuroepithelial tumors: a case report and review of the literature. Child Neurol Open 2:2329048X14567531.  https://doi.org/10.1177/2329048X14567531 CrossRefGoogle Scholar
  5. 5.
    Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D et al (2012) Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 124:627–641.  https://doi.org/10.1007/s00401-012-1037-x CrossRefGoogle Scholar
  6. 6.
    Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 129:609–610.  https://doi.org/10.1007/s00401-015-1400-9 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Jason Chiang
    • 1
    Email author
  • James Dalton
    • 2
  • Santhosh A. Upadhyaya
    • 3
  • Zoltán Patay
    • 4
  • Ibrahim Qaddoumi
    • 3
  • Xiaoyu Li
    • 1
  • Annette D. Segura
    • 5
  • Suash Sharma
    • 6
  • Azzam Ismail
    • 7
  • Sheila A. Shurtleff
    • 1
  • Susana C. Raimondi
    • 2
  1. 1.Department of PathologySt. Jude Children’s Research HospitalMemphisUSA
  2. 2.Cytogenetics Laboratory, Department of PathologySt. Jude Children’s Research HospitalMemphisUSA
  3. 3.Division of Neuro-Oncology, Department of OncologySt. Jude Children’s Research HospitalMemphisUSA
  4. 4.Department of Diagnostic ImagingSt. Jude Children’s Research HospitalMemphisUSA
  5. 5.Department of PathologyChildren’s Hospital of WisconsinMilwaukeeUSA
  6. 6.Department of PathologyMedical College of Georgia at Augusta UniversityAugustaUSA
  7. 7.Department of HistopathologySt James’s University HospitalLeedsUK

Personalised recommendations